Apollo Health Ventures — Full Portfolio
10 tracked investments · listed companies and verified rows first
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.
BiotechHealthtech
Frédéric Marrache(Co-founder & CEO)in
Co-investorsJeito CapitalSanofi VenturesSofinnova PartnersVIVES PartnersSixty Degree Capital
Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.
BiotechDeep TechLongevity
Diogo R. Feleciano(Co-Founder & CSO)inDarci J. Trader(Scientific Co-Founder / Advisor)João Ribas(Interim-CBO)in
Co-investorsNovo HoldingsKorify Capital
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in
Co-investorsBroadview VenturesSofinnova Partners+ND Capital4see Ventures
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease.
BiotechDeep TechLongevityBoston, US
Co-investorsCoastCapKorify CapitalAndreessen Horowitz
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsJoyance PartnersPsyMed VenturesSocial StartsLeaps by Bayer
Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.
BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL
Peter de Keizer(Founder and Managing Director)inTobias Madl(Head of Structural Biology, Scientific Co-founder)
Co-investorsCoastCapCurie CapitalKorify CapitalKurma PartnersROM Utrecht Region
Cognito is a Canadian online mental health service offering cognitive behavioral therapy and psychiatric care for anxiety, depression, insomnia, and ADHD.
Digital HealthHealthtechMental HealthVictoria, CA
Co-investorsGarage CapitalGraphite VenturesIAG Capital Partners
BiotechSt. Petersburg, US
Christopher Shepard(Executive Officer, Director)inJarod Rutledge(Director)
BoardNils Regge(Director)in
Co-investorsKorify Capital
Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.
BiotechDeep TechHealthtechLongevity
Victor Bustos(Co-Founder & CEO)inWolfgang Link(Scientific Co-founder & Advisor)inAndrew Pierce(Chief Science Officer)in
Co-investorsKorify CapitalBoehringer Ingelheim Venture FundHTGF
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesMitsui Global InvestmentDementia Discovery Fund+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.